Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amylin analogue/insulin glargine - Biozeus

Next Previous
Drug Profile

Amylin analogue/insulin glargine - Biozeus

Alternative Names: BZ 043A

Latest Information Update: 24 May 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Unknown
  • Developer Biozeus
  • Class Antihyperglycaemics; Insulins; Macromolecular substances; Pancreatic hormones; Proteins
  • Mechanism of Action Insulin receptor agonists; Islet amyloid polypeptide stimulants; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Type 1 diabetes mellitus

Most Recent Events

  • 24 May 2021 Discontinued - Preclinical for Type 1 diabetes mellitus in Brazil (SC), prior to May 2021 (Biozeus pipeline, May 2021)
  • 07 Aug 2018 BZ 043A is available for licensing as of 07 Aug 2018. http://biozeus.com.br/
  • 22 Jun 2018 Pharmacodynamics data from preclinical trials in Type-1 diabetes mellitus presented at the 78th Annual Scientific Sessions of the American Diabetes Association (ADA-2018)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top